Cas:616-75-1 Benzylmalonic Acid manufacturer & supplier

We serve Chemical Name:Benzylmalonic Acid CAS:616-75-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Benzylmalonic Acid

Chemical Name:Benzylmalonic Acid
CAS.NO:616-75-1
Synonyms:MFCD00004261;2-benzylpropanedioic acid;EINECS 210-491-5
Molecular Formula:C10H10O4
Molecular Weight:194.18400
HS Code:2917399090

Physical and Chemical Properties:
Melting point:117-120 °C(lit.)
Boiling point:378.4ºC at 760 mmHg
Density:1.34 g/cm3
Index of Refraction:
PSA:74.60000
Exact Mass:194.05800
LogP:1.01450

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like MFCD00004261 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 210-491-5 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-benzylpropanedioic acid Use and application,EINECS 210-491-5 technical grade,usp/ep/jp grade.


Related News: We are pleased that intravenous rigosertib will be made compliantly available to suitable patients with higher-risk MDS through their physicians in designated countries. Benzylmalonic Acid manufacturer With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand. Benzylmalonic Acid supplier Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding. Benzylmalonic Acid vendor For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. Benzylmalonic Acid factory Retrogenix��s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.